MedPath
NMPA Approval

Drotaverine Hydrochloride Injection

国药准字H20065923

March 1, 2021

国药准字H20065923

Drug Information

盐酸屈他维林注射液

注射剂

2ml:40mg(以 C₂₄H₃₁NO₄•HCl 计)

化学药品

March 1, 2021

Company Information

Applicant Company

江苏省扬州市扬州生物健康产业园健康一路9号

Manufacturing Company

江苏省扬州市扬州生物健康产业园健康一路9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸屈他维林注射液 - NMPA 批准文号 | MedPath